Search Results

Filter
  • 1-10 of  590 results for ""Cyclooxygenase 2 Inhibitors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Fixed drug eruption secondary to etoricoxib.

  • Authors : Rawlings N; Department of Oral Medicine, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Joshi S

Subjects: Etoricoxib*/Etoricoxib*/Etoricoxib*/adverse effects ; Drug Eruptions*/Drug Eruptions*/Drug Eruptions*/etiology ; Pyridines*/Pyridines*/Pyridines*/adverse effects

  • Source: The British journal of oral & maxillofacial surgery [Br J Oral Maxillofac Surg] 2024 Jul; Vol. 62 (6), pp. 571-574. Date of Electronic Publication: 2024 May 15.Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 8405235 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Design, Synthesis and Biological Evaluation of New N-Acyl Hydrazones with a Methyl Sulfonyl Moiety as Selective COX-2 Inhibitors.

  • Authors : Osmaniye D; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470, Eskişehir, Turkey.; Doping and Narcotic Compounds Analysis Research Laboratory, Faculty of Pharmacy, Anadolu University, 26470, Eskişehir, Turkey.

Subjects: Drug Design*; Cyclooxygenase 2/Cyclooxygenase 2/Cyclooxygenase 2/*metabolism ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*pharmacology

  • Source: Chemistry & biodiversity [Chem Biodivers] 2021 Nov; Vol. 18 (11), pp. e2100521. Date of Electronic Publication: 2021 Sep 29.Publisher: Verlag Helvetica Chimica Acta Country of Publication: Switzerland NLM ID: 101197449 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Automatic evaluation of cyclooxygenase 2 inhibition induced by metal-based anticancer compounds.

  • Authors : Pereira SAP; REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.; Bobbink FD

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Cyclooxygenase 2/Cyclooxygenase 2/Cyclooxygenase 2/*chemistry ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*pharmacology

  • Source: Journal of inorganic biochemistry [J Inorg Biochem] 2021 May; Vol. 218, pp. 111399. Date of Electronic Publication: 2021 Feb 16.Publisher: Elsevier Country of Publication: United States NLM ID: 7905788 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging.

  • Authors : Xie L; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States.; Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian 350007, PR China.

Subjects: Optical Imaging*; Biocompatible Materials/Biocompatible Materials/Biocompatible Materials/*pharmacology ; Cyclooxygenase 2/Cyclooxygenase 2/Cyclooxygenase 2/*metabolism

  • Source: ACS applied bio materials [ACS Appl Bio Mater] 2021 Mar 15; Vol. 4 (3), pp. 2723-2731. Date of Electronic Publication: 2021 Feb 28.Publisher: ACS Publications Country of Publication: United States NLM ID: 101729147 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.

  • Authors : Sağlık BN; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470, Eskişehir, Turkey; Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26470, Eskişehir, Turkey.

Subjects: Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*chemical synthesis ; Cyclooxygenase 2/Cyclooxygenase 2/Cyclooxygenase 2/*metabolism ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*chemical synthesis

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2021 Jan 01; Vol. 209, pp. 112918. Date of Electronic Publication: 2020 Oct 09.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold.

  • Authors : Reale A; Dipartimento di Biotecnologie, Chimica e Farmacia, (Dipartimento d'Eccellenza 2018-2022), Università di Siena, Via A. Moro, I-53100 Siena, Italy.; Brogi S

Subjects: Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*therapeutic use ; Pyrroles/Pyrroles/Pyrroles/*therapeutic use ; Sulfides/Sulfides/Sulfides/*therapeutic use

  • Source: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2019 Oct 01; Vol. 27 (19), pp. 115045. Date of Electronic Publication: 2019 Aug 09.Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pharmacokinetics of the novel COX-2 selective inhibitor vitacoxib in cats: The effects of feeding and dose.

  • Authors : Wang J; Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China.; Laboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural affairs of the People's Republic of China, Beijing, China.

Subjects: Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*pharmacokinetics ; Imidazoles/Imidazoles/Imidazoles/*pharmacokinetics ; Sulfones/Sulfones/Sulfones/*pharmacokinetics

  • Source: Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2019 May; Vol. 42 (3), pp. 294-299. Date of Electronic Publication: 2019 Feb 08.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7910920 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.

  • Authors : Curtis E; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.; Fuggle N

Subjects: Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*adverse effects ; Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/Drug-Related Side Effects and Adverse Reactions/*etiology ; Lactones/Lactones/Lactones/*adverse effects

  • Source: Drugs & aging [Drugs Aging] 2019 Apr; Vol. 36 (Suppl 1), pp. 25-44.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs.

  • Authors : Wang J; Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China.; Laboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural Affairs of the People's Republic of China, Beijing, China.

Subjects: Computer Simulation* ; Models, Biological*; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*pharmacokinetics

  • Source: Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2019 Sep; Vol. 42 (5), pp. 530-540. Date of Electronic Publication: 2019 Aug 01.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7910920 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Evaluation of pharmacokinetic properties of vitacoxib in fasted and fed horses.

  • Authors : Wang J; Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China.; Laboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural affairs, Beijing, China.

Subjects: Food Deprivation*; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*pharmacokinetics ; Horses/Horses/Horses/*blood

  • Source: Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2018 Dec; Vol. 41 (6), pp. 843-847. Date of Electronic Publication: 2018 Aug 03.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7910920 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  590 results for ""Cyclooxygenase 2 Inhibitors""